|
|
 2017 ; Vol.27-4: 785~790
Author | Hyun Woo Lee, Hansol Choi, Sang-Jip Nam, William Fenical, Hoon Kim |
Place of duty | Department of Pharmacy and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea |
Title | Potent Inhibition of Monoamine Oxidase B by a Piloquinone from Marine-Derived Streptomyces sp. CNQ-027 |
PublicationInfo |
J. Microbiol. Biotechnol.2017 ;
Vol.27-4
|
Abstract | Two piloquinone derivatives isolated from Streptomyces sp. CNQ-027 were tested for the
inhibitory activities of two isoforms of monoamine oxidase (MAO), which catalyzes
monoamine neurotransmitters. The piloquinone 4,7-dihydroxy-3-methyl-2-(4-methyl-1-
oxopentyl)-6H-dibenzo[b,d]pyran-6-one (1) was found to be a highly potent inhibitor of
human MAO-B, with an IC50 value of 1.21 ¥ìM; in addition, it was found to be highly effective
against MAO-A, with an IC50 value of 6.47 ¥ìM. Compound 1 was selective, but not extremely
so, for MAO-B compared with MAO-A, with a selectivity index value of 5.35. Compound 1,8-
dihydroxy-2-methyl-3-(4-methyl-1-oxopentyl)-9,10-phenanthrenedione (2) was moderately
effective for the inhibition of MAO-B (IC50 = 14.50 ¥ìM) but not for MAO-A (IC50 > 80 ¥ìM).
There was no time-dependency in inhibition of MAO-A or -B by compound 1, and the MAO-A
and -B activities were almost completely recovered in the dilution experiments with an excess
amount of compound 1. Compound 1 showed competitive inhibition for MAO-A and -B, with
Ki values of 0.573 and 0.248 ¥ìM, respectively. These results suggest that piloquinones from a
microbial source could be potent reversible MAO inhibitors and may be useful lead
compounds for developing MAO enzyme inhibitors to treat related disorders, such as
depression, Parkinson¡¯s disease, and Alzheimer¡¯s disease. |
Full-Text |  |
Key_word | Monoamine oxidase, piloquinone, Streptomyces sp. CNQ-027, potent selective inhibitor, competitive inhibitor |
References |
Ramsay RR. 2012. Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery. Curr. Top. Med. Chem. 12: 2189-2209. Orhan IE. 2016. Potential of natural products of herbal origin as monoamine oxidase inhibitors. Curr. Pharm. Des. 22: 268-276. Riederer P, Lachenmayer L, Laux G. 2004. Clinical applications of MAO-inhibitors. Curr. Med. Chem. 11: 2033-2043. Youdim MB, Edmondson D, Tipton KF. 2006. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7: 295-309. Mostert S, Petzer A, Petzer JP. 2015. Indanones as high-potency reversible inhibitors of monoamine oxidase. ChemMedChem 10: 862-873. Carradori S, Gidaro MC, Petzer A, Costa G, Guglielmi P, Chimenti P, et al. 2016. Inhibition of human monoamine oxidase: biological and molecular modeling studies on selected natural flavonoids. J. Agric. Food Chem. 64: 9004-9011. Chaurasiya ND, Gogineni V, Elokely KM, León F, Núñez MJ, Klein ML, et al. 2016. Isolation of acacetin from Calea urticifolia with inhibitory properties against human monoamine oxidase-A and -B. J. Nat. Prod. 79: 2538-2544. Ramsay RR. 2016. Molecular aspects of monoamine oxidase B. Prog. Neuropsychopharmacol. Biol. Psychiatry 69: 81-89. Van der Walt MM, Terre¡¯Blanche G, Petzer JP, Petzer A. 2017. Benzyloxynitrostyrene analogues - a novel class of selective and highly potent inhibitors of monoamine oxidase B. Eur. J. Med. Chem. 125: 1193-1199. Fajemiroye JO, da Silva DM, de Oliveira DR, Costa EA. 2016. Treatment of anxiety and depression: medicinal plants in retrospect. Fundam. Clin. Pharmacol. 30: 198-215. Mathew B, Suresh J, Mathew GE, Parasuraman R, Abdulla N. 2014. Plant secondary metabolites - potent inhibitors of monoamine oxidase isoforms. Cent. Nerv. Syst. Agents Med. Chem. 14: 28-33. Carradori S, D¡¯Ascenzio M, Chimenti P, Secci D, Bolasco A. 2014. Selective MAO-B inhibitors: a lesson from natural products. Mol. Divers. 18: 219-243. Takeuchi T, Ogawa K, Iinuma H, Suda H, Ukita K, Nagatsu T, et al. 1973. Monoamine oxidase inhibitors isolated from fermented broths. J. Antibiot. 26: 162-167. Lee IK, Yun B S, Oh S, K im Y H, L ee MK, Y oo ID. 19 9 9. 5-Methylmellein and nectriapyrone, two new monoamine oxidase inhibitors. Med. Sci. Res. 27: 463-465. Lee HW, Jung WK, Kim HJ, Jeong YS, Nam SJ, Kang H, Kim H. 2015. Inhibition of monoamine oxidase by anithiactins from Streptomyces sp. J. Microbiol. Biotechnol. 25: 1425-1428. Lee HW, Kim YJ, Nam SJ, Kim H. 2016. Potent selective inhibition of monoamine oxidase A by alternariol monomethyl ether isolated from Alternaria brassicae. J. Microbiol. Biotechnol. 27: 316-320. Fenical W, Jensen PR. 2006. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2: 666-673. Nam SJ, Kauffman CA, Jensen PR, Fenical W. 2011. Isolation and characterization of actinoramides A-C, highly modified peptides from a marine Streptomyces sp. Tetrahedron 67:6707-6712. Gaudemer A, Polonsky J. 1964. Nuclear magnetic resonance of piloquinone and its derivatives. Bull. Soc. Chim. Fr. 8:1918-1923. Polonsky J, Lederer E. 1963. Piloquinone: a new phenanthreneO-quinone isolated from the mycelium of Streptomyces pilosus. Nature 199: 285-286. Jokela R, Lounasmaa M. 1997. Complete 1H- and 13C-NMR spectral data of piloquinone, a 9,10-phenanthrenequinone derivative from Streptomyces pilosus. Planta Med. 63: 85-86. Legoabe LJ, Petzer A, Petzer JP. 2012. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Eur. J. Med. Chem. 49: 343-353. Petzer A, Harvey BH, Petzer JP. 2014. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase. Toxicol. Appl. Pharmacol. 274: 488493. Lee MK, Hwang BY, Lee SA, Oh GJ, Choi WH, Hong SS, et al. 2003. 1-Methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase. Chem. Pharm. Bull. (Tokyo) 51: 409-411. Kong LD, Cheng CH, Tan RX. 2004. Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J. Ethnopharmacol. 91: 351-355. Choi WH, Hong SS, Lee SA, Han XH, Lee KS, Lee MK, et al. 2005. Monoamine oxidase inhibitory naphthoquinones from the roots of Lithospermum erythrorhizon. Arch. Pharm. Res. 28:400-404. Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H. 2016. Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg. Med. Chem. Lett. 26: 4714-4719.
|
|
|